{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:26:20Z","timestamp":1793964380301,"version":"4.8.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["510-2010"],"award-info":[{"award-number":["510-2010"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To quantify the association between maternal uric acid levels and pre-eclampsia risk in a large collection of primigravid women. A case\u2013control study (1365 cases of pre-eclampsia and 1886 normotensive controls) was conducted. Pre-eclampsia was defined as blood pressure\u2009\u2265\u2009140\/90\u00a0mmHg and proteinuria\u2009\u2265\u2009300\u00a0mg\/24\u00a0h. Sub-outcome analysis included early, intermediate, and late pre-eclampsia. Multivariable analysis for pre-eclampsia and its sub-outcomes was conducted using binary and multinomial logistic regression, respectively. Additionally, a systematic review and meta-analysis of cohort studies measuring uric acid levels\u2009&lt;\u200920\u00a0weeks of gestation was performed to rule out reverse causation. There was a positive linear association between increasing uric acid levels and presence of pre-eclampsia. Adjusted odds ratio of pre-eclampsia was 1.21 (95%CI 1.11\u20131.33) for every one standard deviation increase in uric acid levels. No differences in the magnitude of association were observed between early and late pre-eclampsia. Three studies with uric acid measured\u2009&lt;\u200920\u00a0weeks\u2019 gestation were identified, with a pooled OR for pre-eclampsia of 1.46 (95%CI 1.22\u20131.75) for a top vs. bottom quartile comparison. Maternal uric acid levels are associated with risk of pre-eclampsia. Mendelian randomisation studies would be helpful to further explore the causal role of uric acid in pre-eclampsia.<\/jats:p>","DOI":"10.1038\/s41598-023-29651-4","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T11:05:17Z","timestamp":1676977517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Uric acid and risk of pre-eclampsia: results from a large case\u2013control study and meta-analysis of prospective studies"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1847-4282","authenticated-orcid":false,"given":"Claudia C.","family":"Colmenares-Mejia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8875-0110","authenticated-orcid":false,"given":"Doris C.","family":"Quintero-Lesmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-324X","authenticated-orcid":false,"given":"Paula K.","family":"Bautista-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-3465","authenticated-orcid":false,"given":"Elizabeth","family":"Gu\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0310-0125","authenticated-orcid":false,"given":"Maria C.","family":"Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8186-9124","authenticated-orcid":false,"given":"David","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-3724","authenticated-orcid":false,"given":"Kathryn J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1898-6862","authenticated-orcid":false,"given":"Juan P.","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3532-2002","authenticated-orcid":false,"given":"Norma C.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"issue":"9461","key":"29651_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai, B., Dekker, G. & Kupferminc, M. Pre-eclampsia. Lancet 365(9461), 785\u2013799 (2005).","journal-title":"Lancet"},{"issue":"9516","key":"29651_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan, K. S., Wojdyla, D., Say, L., G\u00fclmezoglu, A. M. & Van Look, P. F. WHO analysis of causes of maternal death: A systematic review. Lancet 367(9516), 1066\u20131074 (2006).","journal-title":"Lancet"},{"issue":"7491","key":"29651_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","volume":"330","author":"K Duckitt","year":"2005","unstructured":"Duckitt, K. & Harrington, D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. Br. Med. J. 330(7491), 565\u2013567 (2005).","journal-title":"Br. Med. J."},{"key":"29651_CR4","first-page":"259","volume":"64","author":"HM Salihu","year":"2012","unstructured":"Salihu, H. M., De-La-Cruz, C., Rahman, S. & August, E. M. Does maternal obesity cause preeclampsia? A systematic review of the evidence. Miner. Ginecol. 64, 259\u2013280 (2012).","journal-title":"Miner. Ginecol."},{"key":"29651_CR5","first-page":"31","volume":"2010","author":"EAP Steegers","year":"2010","unstructured":"Steegers, E. A. P., Von Dadelszen, P., Duvekot, J. J. & Pijnenborg, R. Pre-eclampsia. Lancet 2010, 31\u201344 (2010).","journal-title":"Lancet"},{"issue":"1","key":"29651_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1177\/1753944708097114","volume":"3","author":"A Hawfield","year":"2009","unstructured":"Hawfield, A. & Freedman, B. I. Pre-eclampsia: The pivotal role of the placenta in its pathophysiology and markers for early detection. Therapeut. Adv. Cardiovasc. Dis. 3(1), 65\u201373 (2009).","journal-title":"Therapeut. Adv. Cardiovasc. Dis."},{"issue":"7","key":"29651_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350(7), 672\u2013683 (2004).","journal-title":"N. Engl. J. Med."},{"key":"29651_CR8","unstructured":"National Institute for Health and Care Excellence. Overview|Hypertension in pregnancy: Diagnosis and management|Guidance|NICE. NICE Guidel [Internet] (2020, accessed 22 Jul 2021); https:\/\/www.nice.org.uk\/guidance\/ng133."},{"issue":"1","key":"29651_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.placenta.2007.11.001","volume":"29","author":"SA Bainbridge","year":"2008","unstructured":"Bainbridge, S. A. & Roberts, J. M. Uric acid as a pathogenic factor in preeclampsia. Placenta 29(1), 67\u201372 (2008).","journal-title":"Placenta"},{"issue":"2","key":"29651_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1573402111666150529130703","volume":"11","author":"S Masoura","year":"2015","unstructured":"Masoura, S. et al. The involvement of uric acid in the pathogenesis of preeclampsia. Curr. Hypertens. Rev. 11(2), 110\u2013115 (2015).","journal-title":"Curr. Hypertens. Rev."},{"issue":"1","key":"29651_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejogrb.2009.05.014","volume":"146","author":"CM Koopmans","year":"2009","unstructured":"Koopmans, C. M. et al. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: Bivariate meta-analysis and decision analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 146(1), 8\u201314 (2009).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"29651_CR12","first-page":"1","volume":"15","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. Dose\u2013response association between serum uric acid levels and incident hypertension: A systematic review and meta-analysis of 17 prospective cohort studies of 32 thousand participants. Acta Cardiol. 15, 1\u20136 (2020).","journal-title":"Acta Cardiol."},{"key":"29651_CR13","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ndt\/gft029","volume":"28","author":"RJ Johnson","year":"2013","unstructured":"Johnson, R. J. et al. Uric acid and chronic kidney disease: Which is chasing which?. Nephrol. Dial. Transplant. 28, 2221\u20132228 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"29651_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/oxfordjournals.molbev.a004123","volume":"19","author":"M Oda","year":"2002","unstructured":"Oda, M., Satta, Y., Takenaka, O. & Takahata, N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol. Biol. Evol. 19(5), 640\u2013653 (2002).","journal-title":"Mol. Biol. Evol."},{"issue":"11","key":"29651_CR15","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames, B. N., Cathcart, R., Schwiers, E. & Hochstein, P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc. Natl. Acad. Sci. USA 78(11), 6858\u20136862 (1981).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"29651_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.HYP.0000028589.66335.AA","volume":"40","author":"S Watanabe","year":"2002","unstructured":"Watanabe, S. et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 40(3), 355\u2013360 (2002).","journal-title":"Hypertension"},{"issue":"1","key":"29651_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson, P. C., Young Kim, S., Lavalley, M. & Choi, H. K. Hyperuricemia and incident hypertension: A systematic review and meta-analysis. Arthritis Care Res. 63(1), 102\u2013110 (2011).","journal-title":"Arthritis Care Res."},{"key":"29651_CR18","first-page":"12","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Hyperuricemia and risk of incident hypertension: A systematic review and meta-analysis of observational studies. PLoS ONE 9, 12 (2014).","journal-title":"PLoS ONE"},{"issue":"1","key":"29651_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ije\/dys066","volume":"42","author":"A Fraser","year":"2013","unstructured":"Fraser, A. et al. Cohort profile: The avon longitudinal study of parents and children: ALSPAC mothers cohort. Int. J. Epidemiol. 42(1), 97\u2013110 (2013).","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"29651_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ajh.2010.262","volume":"24","author":"SK Laughon","year":"2011","unstructured":"Laughon, S. K., Catov, J., Powers, R. W., Roberts, J. M. & Gandley, R. E. First trimester uric acid and adverse pregnancy outcomes. Am. J. Hypertens. 24(4), 489\u2013495 (2011).","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"29651_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1471-0528.2011.03232.x","volume":"119","author":"TL-A Hawkins","year":"2012","unstructured":"Hawkins, T.L.-A. et al. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: A retrospective cohort study. BJOG An Int. J. Obstet. Gynaecol. 119(4), 484\u2013492 (2012).","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"issue":"2","key":"29651_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0301-2115(97)00248-0","volume":"77","author":"P Merviel","year":"1998","unstructured":"Merviel, P. et al. Lone hyperuricemia during pregnancy: Maternal and fetal outcomes. Eur. J. Obstet. Gynecol. Reprod. Biol. 77(2), 145\u2013150 (1998).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"29651_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/0144361021000043155","volume":"23","author":"DS Weerasekera","year":"2003","unstructured":"Weerasekera, D. S. & Peiris, H. The significance of serum uric acid, creatinine and urinary microprotein levels in predicting pre-eclampsia. J. Obstet. Gynaecol. (Lahore) 23(1), 17\u201319 (2003).","journal-title":"J. Obstet. Gynaecol. (Lahore)"},{"issue":"8","key":"29651_CR24","doi-asserted-by":"publisher","first-page":"e0272165","DOI":"10.1371\/journal.pone.0272165","volume":"17","author":"F Hassen","year":"2022","unstructured":"Hassen, F., Malik, T. & Dejenie, T. Evaluation of serum uric acid and liver function tests among pregnant women with and without preeclampsia at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. PLoS ONE 17(8), e0272165 (2022).","journal-title":"PLoS ONE"},{"issue":"6","key":"29651_CR25","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1080\/13813455.2020.1773863","volume":"128","author":"A Shakarami","year":"2022","unstructured":"Shakarami, A., Ghafarzadeh, M., Yari, F. & Fathi, L. Association between maternal serum uric acid and preeclampsia. Arch. Physiol. Biochem. 128(6), 1434\u20131437 (2022).","journal-title":"Arch. Physiol. Biochem."},{"issue":"12","key":"29651_CR26","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.3109\/14767058.2012.705396","volume":"25","author":"K Watanabe","year":"2012","unstructured":"Watanabe, K. et al. Increased oxidant generation in the metabolism of hypoxanthine to uric acid and endothelial dysfunction in early-onset and late-onset preeclamptic women. J. Matern. Neonatal. Med. 25(12), 2662\u20132666 (2012).","journal-title":"J. Matern. Neonatal. Med."},{"issue":"6","key":"29651_CR27","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00404-021-06313-2","volume":"305","author":"ELSS de Mendon\u00e7a","year":"2022","unstructured":"de Mendon\u00e7a, E. L. S. S., da Silva, J. V. F., Mello, C. S. & de Oliveira, A. C. M. Serum uric acid levels associated with biochemical parameters linked to preeclampsia severity and to adverse perinatal outcomes. Arch. Gynecol. Obstet. 305(6), 1453\u20131463 (2022).","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1","key":"29651_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0021-9258(18)86658-3","volume":"32","author":"JM Slemons","year":"1917","unstructured":"Slemons, J. M. & Bogert, L. J. The uric acid content of maternal and fetal blood. J. Biol. Chem. 32(1), 63\u201369 (1917).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"29651_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/AOG.0000000000003408","volume":"134","author":"NC Chescheir","year":"2019","unstructured":"Chescheir, N. C. Serum uric acid measurement in women with hypertensive disorders of pregnancy. Obstet. Gynecol. 134(3), 636\u2013638 (2019).","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"29651_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1471-0528.2006.00908.x","volume":"113","author":"S Thangaratinam","year":"2006","unstructured":"Thangaratinam, S., Ismail, K. M. K., Sharp, S., Coomarasamy, A. & Khan, K. S. Accuracy of serum uric acid in predicting complications of pre-eclampsia: A systematic review. BJOG An Int. J. Obstet. Gynaecol. 113(4), 369\u2013378 (2006).","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"issue":"6","key":"29651_CR31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1600-0897.2010.00960.x","volume":"65","author":"MJMJ Mulla","year":"2011","unstructured":"Mulla, M. J. M. J. et al. Uric acid induces trophoblast IL-1\u03b2 production via the inflammasome: Implications for the pathogenesis of preeclampsia. Am. J. Reprod. Immunol. 65(6), 542\u2013548 (2011).","journal-title":"Am. J. Reprod. Immunol."},{"key":"29651_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1152\/ajpcell.00593.2008","volume":"297","author":"SA Bainbridge","year":"2009","unstructured":"Bainbridge, S. A. et al. Uric acid attenuates trophoblast invasion and integration into endothelial cell monolayers. Am. J. Physiol. Cell Physiol. 297, 2 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"12","key":"29651_CR33","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1681\/ASN.2005050572","volume":"16","author":"DH Kang","year":"2005","unstructured":"Kang, D. H., Park, S. K., Lee, I. K. & Johnson, R. J. Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells. J. Am. Soc. Nephrol. 16(12), 3553\u20133562 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"32","key":"29651_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.niox.2013.04.003","volume":"1","author":"JH Park","year":"2013","unstructured":"Park, J. H. et al. Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: A mechanism for uric acid-induced cardiovascular disease development. Nitric Oxide Biol. Chem. 1(32), 36\u201342 (2013).","journal-title":"Nitric Oxide Biol. Chem."},{"issue":"6","key":"29651_CR35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1471-0528.1997.tb11979.x","volume":"104","author":"AM G\u00fclmezo\u01e7lu","year":"1997","unstructured":"G\u00fclmezo\u01e7lu, A. M. et al. Antioxidants in the treatment of severe pre-eclampsia: An explanatory randomised controlled trial. Br. J. Obstet. Gynaecol. 104(6), 689\u2013696 (1997).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"29651_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/ndt\/gft378","volume":"29","author":"B Bose","year":"2014","unstructured":"Bose, B. et al. Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis. Nephrol. Dial. Transplant. 29, 406\u2013413 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"29651_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1751-7176.2012.00701.x","volume":"15","author":"V Agarwal","year":"2013","unstructured":"Agarwal, V., Hans, N. & Messerli, F. H. Effect of allopurinol on blood pressure: A systematic review and meta-analysis. J. Clin. Hypertens. (Greenw.) 15, 435\u2013442 (2013).","journal-title":"J. Clin. Hypertens. (Greenw.)"},{"issue":"2","key":"29651_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng.2500","volume":"45","author":"A K\u00f6ttgen","year":"2013","unstructured":"K\u00f6ttgen, A. et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat. Genet. 45(2), 145\u2013154 (2013).","journal-title":"Nat. Genet."},{"issue":"3\u20134","key":"29651_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000504267","volume":"104","author":"JY Ge","year":"2020","unstructured":"Ge, J. Y., Ji, Y., Zhu, Z. Y. & Li, X. Genetically elevated serum uric acid and renal function in an apparently healthy population. Urol. Int. 104(3\u20134), 277\u2013282 (2020).","journal-title":"Urol. Int."},{"key":"29651_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pmed.1002937","volume":"16","author":"X Li","year":"2019","unstructured":"Li, X. et al. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study. PLoS Med. 16, 10 (2019).","journal-title":"PLoS Med."},{"issue":"11","key":"29651_CR41","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1681\/ASN.2014070660","volume":"26","author":"ME Kleber","year":"2015","unstructured":"Kleber, M. E. et al. Uric acid and cardiovascular events: A Mendelian randomization study. J. Am. Soc. Nephrol. 26(11), 2831\u20132838 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"29651_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S2213-8587(15)00386-1","volume":"4","author":"J White","year":"2016","unstructured":"White, J. et al. Plasma urate concentration and risk of coronary heart disease: A Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 4(4), 327\u2013336 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1\u20132","key":"29651_CR43","first-page":"141","volume":"24","author":"L Morgan","year":"2014","unstructured":"Morgan, L. et al. InterPregGen: Genetic studies of pre-eclampsia in three continents. Nor. Epidemiol. 24(1\u20132), 141\u2013146 (2014).","journal-title":"Nor. Epidemiol."},{"key":"29651_CR44","unstructured":"Departamento Administrativo Nacional de Estad\u00edstica. Estratificaci\u00f3n Socioecon\u00f3mica [Internet] (2019, accessed 17 Feb 2019); https:\/\/www.dane.gov.co\/files\/geoestadistica\/Preguntas_frecuentes_estratificacion.pdf."},{"issue":"12","key":"29651_CR45","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.clinthera.2012.10.008","volume":"34","author":"S Kabul","year":"2012","unstructured":"Kabul, S. & Shepler, B. A review investigating the effect of allopurinol on the progression of kidney disease in hyperuricemic patients with chronic kidney disease. Clin. Ther. 34(12), 2293\u20132296 (2012).","journal-title":"Clin. Ther."},{"key":"29651_CR46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000360609","volume":"39","author":"M Kanbay","year":"2014","unstructured":"Kanbay, M. et al. Effects of allopurinol on endothelial dysfunction: A meta-analysis. Am. J. Nephrol. 39, 348\u2013356 (2014).","journal-title":"Am. J. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29651-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T14:09:37Z","timestamp":1676988577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29651-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29651"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29651-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DJW is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre.\u00a0KJG reports consulting for Roche, Aetion, and BillionToOne outside the scope of the submitted work. \nRemain authors declare that there are no conflict of interests regarding the publication of this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3018"}}